Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
Open Access
- 13 January 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 5, 465
Abstract
Homoharringtonine (HHT) has been widely used in China to treat patients with acute and chronic myeloid leukemia for decades. Since response to HHT varies among patients, our study aimed to identify biomarkers that might influence the response to HHT using a panel of various human lymphoblastoid cell lines (LCLs). Genome-wide association (GWA) analysis using single nucleotide polymorphism (SNP) and mRNA expression data was assessed for association with cytotoxicity to HHT in LCLs. Integrated analysis among SNPS, expression, AUC value was also performed to help select candidate genes for further functional characterization. Functional validation of candidate genes was performed using leukemia cell lines (U937, K562). Candidate genes were knocked down using specific siRNA and its response to HHT was assessed using MTS assay. We found that 15 expression probes were associated with HHT AUC with P value<10-4, and 96 individual probe sets with P value<10-3. Eighteen SNPs were associated with HHT AUC with P<10-5 and 281 SNPs with P<10-4. The integrated analysis identified 4 unique SNPs that were associated with both expression and AUC. Functional validation using siRNA knockdown in leukemia cell lines showed that knocking down CCDC88A, CTBP2, SOCS4 genes in U937 and K562 cells significantly altered HHT cytotoxicity. In summary, this study performed with LCLs can help to identify novel biomarker that might contribute to variation in response to HHT therapy.Keywords
This publication has 29 references indexed in Scilit:
- Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot studyLeukemia, 2011
- Genomics and Drug ResponseNew England Journal of Medicine, 2011
- A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityLeukemia, 2010
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating AktCancer Cell, 2009
- NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2 associationOncogene, 2009
- Genome-wide detection and characterization of positive selection in human populationsNature, 2007
- A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicityProceedings of the National Academy of Sciences, 2007
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- Genetic analysis of genome-wide variation in human gene expressionNature, 2004
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001